BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 21470797)

  • 1. Volumetric-modulated arc therapy: effective and efficient end-to-end patient-specific quality assurance.
    O'Daniel J; Das S; Wu QJ; Yin FF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1567-74. PubMed ID: 21470797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-specific 3D pretreatment and potential 3D online dose verification of Monte Carlo-calculated IMRT prostate treatment plans.
    Boggula R; Jahnke L; Wertz H; Lohr F; Wenz F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1168-75. PubMed ID: 21093168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective analysis for patient-specific quality assurance of volumetric-modulated arc therapy plans.
    Li G; Wu K; Peng G; Zhang Y; Bai S
    Med Dosim; 2014; 39(4):309-13. PubMed ID: 24958705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement comparison and Monte Carlo analysis for volumetric-modulated arc therapy (VMAT) delivery verification using the ArcCHECK dosimetry system.
    Lin MH; Koren S; Veltchev I; Li J; Wang L; Price RA; Ma CM
    J Appl Clin Med Phys; 2013 May; 14(2):3929. PubMed ID: 23470927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMRT quality assurance using a second treatment planning system.
    Anjum MN; Parker W; Ruo R; Aldahlawi I; Afzal M
    Med Dosim; 2010; 35(4):274-9. PubMed ID: 19944590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
    Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
    Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of several modulated radiotherapy techniques for head and neck cancer and dosimetric validation of VMAT.
    Stieler F; Wolff D; Schmid H; Welzel G; Wenz F; Lohr F
    Radiother Oncol; 2011 Dec; 101(3):388-93. PubMed ID: 21962821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and use of a 2D-array of ion chambers for brachytherapy dosimetric quality assurance.
    Yewondwossen M
    Med Dosim; 2012; 37(3):250-6. PubMed ID: 22189031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a 2D detector array for patient-specific VMAT QA with different setups.
    Boggula R; Birkner M; Lohr F; Steil V; Wenz F; Wertz H
    Phys Med Biol; 2011 Nov; 56(22):7163-77. PubMed ID: 22025217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of 3D dosimetry for stereotactic volumetric-modulated arc delivery using COMPASS.
    Vikraman S; Manigandan D; Karrthick KP; Sambasivaselli R; Senniandavar V; Ramu M; Rajesh T; Lutz M; Muthukumaran M; Karthikeyan N; Tejinder K
    J Appl Clin Med Phys; 2014 Jan; 16(1):5128. PubMed ID: 25679152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric verification of brain and head and neck intensity-modulated radiation therapy treatment using EDR2 films and 2D ion chamber array matrix.
    Varatharaj C; Ravikumar M; Sathiyan S; Supe SS; Vivek TR; Manikandan A
    J Cancer Res Ther; 2010; 6(2):179-84. PubMed ID: 20622365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VMAT QA: measurement-guided 4D dose reconstruction on a patient.
    Nelms BE; Opp D; Robinson J; Wolf TK; Zhang G; Moros E; Feygelman V
    Med Phys; 2012 Jul; 39(7):4228-38. PubMed ID: 22830756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric validation and clinical implementation of two 3D dose verification systems for quality assurance in volumetric-modulated arc therapy techniques.
    Clemente-Gutiérrez F; Pérez-Vara C
    J Appl Clin Med Phys; 2015 Mar; 16(2):5190. PubMed ID: 26103189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing an optimized patient-specific verification program for volumetric modulated arc therapy.
    Serna A; Mata F; Puchades V
    Med Dosim; 2013; 38(3):274-9. PubMed ID: 23540493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal characterization and in vitro comparison of cell survival following the delivery of 3D-conformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT).
    McGarry CK; Butterworth KT; Trainor C; O'Sullivan JM; Prise KM; Hounsell AR
    Phys Med Biol; 2011 Apr; 56(8):2445-57. PubMed ID: 21427488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commissioning of volumetric modulated arc therapy (VMAT) in a dual-vendor environment.
    Dobler B; Groeger C; Treutwein M; Alvarez-Moret J; Goetzfried T; Weidner K; Haertl P; Koelbl O
    Radiother Oncol; 2011 Apr; 99(1):86-9. PubMed ID: 21458090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the accuracy of 3DVH software estimates of dose to virtual ion chamber and film in composite IMRT QA.
    Olch AJ
    Med Phys; 2012 Jan; 39(1):81-6. PubMed ID: 22225277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of phantom-based and log file patient-specific QA with complexity scores for VMAT.
    Agnew CE; Irvine DM; McGarry CK
    J Appl Clin Med Phys; 2014 Nov; 15(6):4994. PubMed ID: 25493524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.
    Li HH; Rodriguez VL; Green OL; Hu Y; Kashani R; Wooten HO; Yang D; Mutic S
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):65-72. PubMed ID: 25442343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on correlation between 2D and 3D gamma evaluation metrics in patient-specific quality assurance for VMAT.
    Rajasekaran D; Jeevanandam P; Sukumar P; Ranganathan A; Johnjothi S; Nagarajan V
    Med Dosim; 2014; 39(4):300-8. PubMed ID: 24910246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.